OverviewSuggest Edit

AIT Bioscience provides expert bioanalytical assay services for small molecule and biotherapeutic drug programs from early discovery to IND enabling toxicology through clinical studies to NDA/ANDA/BLA filing. Our processes & systems were designed from the ground up by veteran industry experts who thought it was time to approach bioanalytical processes differently. With years of experience in quantitative bioanalysis and drug development support for small biotech and large Pharma companies, our scientific team spent months evaluating the issues that plague current CROs in order to identify a more efficient way to conduct business in a regulatory setting. Our “greenfield” solution: a paperless environment that assures correctness from one step to the next. Instead of addressing issues uncovered in data review after the fact, AIT Bioscience employs novel electronic systems that detect and resolve potential deviations and errors in real time. Plus, you will be able to closely monitor our laboratory’s progress on your project, allowing you to manage your project with greater efficiency. ... Show more
TypePrivate
Founded2009
HQIndianapolis, US
Websiteaitbioscience.com
Employee Ratings4

Latest Updates

Employees (est.) (Feb 2019)57(-1%)

Key People/Management at AIT Bioscience

Terri Pascarelli

Terri Pascarelli

CEO
Mark Cameron

Mark Cameron

VP, Scientific Services, Ligand Binding Assays
Jeff Goddard Vp

Jeff Goddard Vp

Business Development
Timothy Grever Vp

Timothy Grever Vp

Operations
Ron Shoup

Ron Shoup

Ph.D. – Executive Advisor
Robyn Durr-Henry

Robyn Durr-Henry

B.S., M.S., RQAP-GLP – Senior Director, Quality Assurance
Show more

AIT Bioscience Office Locations

AIT Bioscience has an office in Indianapolis
Indianapolis, US (HQ)
7840 Innovation Blvd
Show all (1)
Report incorrect company information

AIT Bioscience Financials and Metrics

Summary Metrics

Founding Date

2009

AIT Bioscience total Funding

$1.5 m

AIT Bioscience latest funding size

$500 k

Time since last funding

4 years ago

AIT Bioscience investors

AIT Bioscience's latest funding round in January 2015 was reported to be $500 k. In total, AIT Bioscience has raised $1.5 m
View all funding rounds
Report incorrect company information

AIT Bioscience Blogs

AIT Bioscience Attends Indiana Life Sciences Summit

Scientists Present Latest Research at the   Indiana Life Sciences Summit     Recently, several scientists and leaders from AIT Bioscience participated in the 15th Annual Indiana Life Sciences Summit in Indianapolis. BioCrossroads ® facilitated this event with the goal of sharing the knowledge and ex…

AIT Bioscience Attends the 2018 APA Conference

Keeping up with the latest in the bioanalytical industry       AIT Bioscience’s Vice President of Operations, Tim Grever, and Principal Investigator, Rob Lappin, attended the 2018 Applied Pharmaceutical Analysis (APA) Conference in Boston, Massachusetts. The APA conference was created by industry le…

AIT Bioscience Attends the 13th Annual Boulder Peptide Symposium

Senior Scientist, Jim Eckstein Presents   Poster on the Analytical Challenges involved   with the Evolving Structures of Therapeutic Peptides     Recently, AIT Bioscience attended the 13th Annual Boulder Peptide Symposium in Boulder, Colorado. During this year’s event, we shared our recent expertise…

Are you tired of out of box, one size fits all solutions to quantitating your biologic drug?

We’ll meet you where you are   with our customized approach     AIT Bioscience knows that when it comes to your biologic drug, there is no one size fits all approach. Thanks to our experienced scientific team and our ability to flex seamlessly across multiple platforms (LC/MS/MS, LC/HRMS, Biotek, MS…

AIT Bioscience Gains FDA Regulatory Insights at AAPS Guidance Forum

Swarna Ramaswamy Attends the 2018 AAPS   Guidance Forum     Recently, AIT Bioscience’s Senior Scientist, Swarna Ramaswamy, attended the 2018 American Association of Pharmaceutical Scientists (AAPS) Guidance Forum in Silver Spring, Maryland. Swarna was among experts in the life sciences industry, FDA…

Continued Growth to Assist Your Needswdxefcqufszuzezftuxetqsqxt

AIT Bioscience Continues to Grow   Recently we have welcomed Gary Gabriel, Ph.D. and Blythe Logan to AIT Bioscience. Both of these individuals will be assisting our commercial and customer-facing activities.       Gary Gabriel, Ph.D.     Gary Gabriel has over fifteen years in the life science indust…
Show more

AIT Bioscience Company Life and Culture

Report incorrect company information

AIT Bioscience Frequently Asked Questions

  • When was AIT Bioscience founded?

    AIT Bioscience was founded in 2009.

  • Who are AIT Bioscience key executives?

    AIT Bioscience's key executives are Terri Pascarelli, Mark Cameron and Jeff Goddard Vp.

  • How many employees does AIT Bioscience have?

    AIT Bioscience has 57 employees.

  • Who are AIT Bioscience competitors?

    Competitors of AIT Bioscience include Hanger, Advanced Oncotherapy and Affymetrix.

  • Where is AIT Bioscience headquarters?

    AIT Bioscience headquarters is located at 7840 Innovation Blvd, Indianapolis.

  • Where are AIT Bioscience offices?

    AIT Bioscience has an office in Indianapolis.

  • How many offices does AIT Bioscience have?

    AIT Bioscience has 1 office.